Ticker: OSTX

OS Therapies Incorporated (NYSE: OSTX) - Quick internal snapshot What's happening inside: management is executing a fast-paced transformation - moving from private financings and convertible notes into a public capital structure, buying the HER2/Lm assets, accelerating OST‑HER2 regulatory work (p...

OS Therapies Incorporated (NYSE: OSTX) - Q1 2025 Financial Overview Key Points: Revenue: The company reported no revenues for both Q1 2025 and Q1 2024. Net Loss: For Q1 2025, OS Therapies posted a net loss of $3.88 million, compared to a net loss of $1.46 million in the prior year. Expenses: Tot...